Le Lézard
Classified in: Health
Subject: PER

Impopharma Inc. Strengthens Management Team and Board of Directors



TORONTO, Oct. 5, 2017 /PRNewswire/ -- Impopharma Inc. today announced the following organizational changes:

In his new role, Mr. Mayers will provide strategic leadership and assume responsibility for day-to-day operations of the organization. He brings 27 years of pharmaceutical experience; most recently as President and founder of Maycore Inc., a business development and consulting solutions company, and previously Managing Partner of Pharm Eng. Technologies. Prior to this, Mr. Mayers was President of WellSpring Pharma Services, where he managed strategic and operational aspects of the CDMO organization. Previously, Mr. Mayers was Vice President Manufacturing Operations at Purdue Pharma, where he managed significant facility expansions and engineered the launch and line extension of such major brands as Targin, Biphentin and OxyNEO. Mr. Mayers also has held leadership positions in Manufacturing, Quality, Research & Development, Operations, Project Management and Strategy for Apotex, Merck KGaA, Taro and SmithKline Beecham.

Mr. Mayers holds an Hons. BSc. Degree in Biological Sciences from the University of Guelph and an MBA from the Rotman School of Business, University of Toronto.

Dr. Odlaug, Impopharma's Executive Chairman, stated "David's extensive experience in the pharmaceutical industry, specifically in the areas of product development and analytical R&D coupled with his in-depth knowledge of the CDMO space make him the ideal person to help build out future."

David Brown joins Impopharma from Teva Ltd, where he was Director, R&D Program Management with responsibility for portfolio selection, project management and technical expertise. Previously, he was Director, Pharmaceutical Development. Dr. Brown began his career in the UK in respiratory drug development at Fisons Plc. After moving to Canada, he worked at RTP Pharma and Patheon Inc.

Dr. Brown holds an Hons. Bachelor of Pharmacy and a Ph.D. in Pharmaceutics from the School of Pharmacy, University of London, United Kingdom.

"We are pleased to announce, David Brown has assumed the role of Senior Director R&D overseeing all aspects of R&D including formulation, product development and analytical services," said Mr. Mayers. "Dr. Brown brings not only over 20 years of experience in project management and product development but his formulation experience in respiratory device products positions us well to serve our clients and develop future projects."

Wayne Kreppner was most recently President and Chief Operating Officer at Concordia International. Mr. Kreppner brings over 20 years of experience as a pharmaceutical operations and R&D executive. A co-founder and former Vice-President of Product Development at Trimel Pharmaceuticals, Mr. Kreppner was responsible for all scientific operations including R&D, clinical development, manufacturing and supply chain. From 1997 to 2008 Mr. Kreppner held various senior roles in operations and regulatory affairs with Biovail Corporation.

Mr. Kreppner holds a Hons. B.Sc. degree in Biochemistry from the University of Western Ontario, an M.Sc. in Medical Science from McMaster University and an MBA from the Ivey School of Business, University of Western Ontario.

Dr. Odlaug noted that "Wayne Kreppner brings a proven track record of experience in the pharmaceutical industry and will further enhance our strategic leadership as a member of our Board."

About Impopharma

Impopharma is a well-resourced development and testing facility with an expert and experienced team located in Concord, Ontario, Canada that specializes in the development and testing of pulmonary and nasal drug delivery systems and ophthalmic, otic, and dermal products. Please visit
www.Impopharma.com.

Contact:
Impopharma Inc.
Vice President, Finance
Tel: (905) 760-0232
Vien Brewster

SOURCE Impopharma Inc.


These press releases may also interest you

at 13:03
Acasti Pharma Inc. , a biopharmaceutical innovator focused on the research, development and commercialization of its prescription drug candidate CaPre®...

at 12:40
Mary C. Titus is recognized by Continental Who's Who as a Pinnacle Professional in the Healthcare field in recognition of her role as Director of Home Health & CNO at St. Joseph Home Health.       Recognized for their wholehearted and compassionate...

at 12:34
Sheppard Pratt Health System has again been named one of the nation's top psychiatric hospitals by U.S. News & World Report in its 2018-19 Best Hospitals rankings. Sheppard Pratt was ranked No. 6 and has been consistently ranked among the top...

at 12:30
TAMPA, Fla., Aug. 14, 2018 /PRNewswire-PRWeb/ -- Altamonte Springs-based Adventist Health System, one of the nation's largest faith-based health care systems, with nearly 50 hospital campuses and more than 80,000 employees, today announced that it...

at 12:29
Portage Biotech Inc. ("Portage" or the "Company") wishes to announce that, subject to regulatory and shareholder consent, it has reached a definitive agreement to acquire 100% of SalvaRx Limited (the "Transaction"). The vendors are SalvaRx Group plc...

at 12:24
Taking place in August, National ASC Month serves to promote awareness of the safe, affordable, exceptional care that ASCs provide. During National ASC Month, ambulatory surgery centers (ASCs) celebrate the high-quality care they provide to surgical...




News published on 5 october 2017 at 17:15 and distributed by: